GET DAILY SIGNALSGenius Sports (GENI) Delivers Strong Q3 Results with First Positive Operating Income
Key Takeaways
- Group revenue rose 62% year over year to $270 million, topping management guidance of $260 million and beating consensus estimates of roughly $260.9 million.
- Genius Sports posted its first-ever quarter of positive GAAP operating income at $10 million, a $36 million improvement from the prior-year period.
- Group adjusted EBITDA climbed about 156% to $87.1 million, exceeding guidance of $85 million and expanding margin to roughly 32%.
- The company generated $54 million in free cash flow, a 61% conversion rate from adjusted EBITDA, as it emphasized cash generation as a core performance metric.
- GAAP net loss narrowed to $15.7 million, or $0.06 per share, an improvement from a $0.11 loss per share a year earlier, though the figure fell short of consensus EPS expectations.
- Full-year 2026 guidance was raised, with revenue now expected between $1.015 billion and $1.035 billion and adjusted EBITDA between $287 million and $297 million.
Earnings Context and Why It Matters
Genius Sports' third-quarter results represent an important milestone for the sports data and technology provider. This marked the company's first full quarter as a combined business after its roughly $1.2 billion acquisition of Legend, a transaction that had weighed on the share price earlier in 2026. The report gave investors their first detailed view of whether the integration is delivering on expected revenue synergies and stronger cash generation. With betting revenue holding up well and the media segment expanding quickly, the quarter tested management's view that the combined operation can turn solid top-line growth into lasting profitability and meaningful free cash flow.
Reported Results
Genius Sports reported third-quarter group revenue of $270 million, up 62% year over year and above its guidance of $260 million. Betting technology revenue grew 33% to approximately $153 million, while media technology revenue surged 126% to about $117 million, driven largely by the Legend acquisition and adoption of the company's Moment Engine advertising product. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Group adjusted EBITDA reached $87.1 million, up about 156% year over year and ahead of the $85 million guided range. The adjusted EBITDA margin expanded to roughly 32%, up about 12 percentage points from the prior-year period. Notably, the company generated $54 million in free cash flow, representing a 61% conversion rate from adjusted EBITDA.
On a GAAP basis, GENI reported operating income of $10 million — its first positive quarter of operating income — while net loss narrowed to $15.7 million, or $0.06 per share, compared with a $0.11 loss per share a year ago. Revenue beat consensus estimates of about $260.9 million, but the GAAP loss per share came in below analyst expectations of roughly breakeven.
Management also raised its full-year 2026 outlook, now projecting revenue of $1.015 billion to $1.035 billion and adjusted EBITDA of $287 million to $297 million, up from prior guidance of $1.005 billion to $1.025 billion and $285 million to $295 million, respectively.
Market Reaction and Investor Sentiment
Heading into the report, investor attention centered on two main questions: whether the Legend integration would justify its purchase price and whether the business could show real cash-generating power. The strong revenue and adjusted EBITDA beats, combined with the free cash flow milestone and raised full-year guidance, addressed those concerns directly. However, the GAAP loss per share landing below consensus tempered enthusiasm, reflecting the ongoing costs associated with the acquisition, including higher interest expense from the $825 million term loan used to fund the deal. The stock closed at $7.01 ahead of the report, down roughly 7.6% over the prior three months, underscoring the market's wait-and-see posture entering earnings.
Forward Outlook and Key Factors to Monitor
Management now expects to end 2026 with approximately $260 million in cash and targets reducing net leverage to roughly 2.0 by year-end, signaling a clear priority on debt repayment following the Legend acquisition. Investors should watch whether the company sustains its free cash flow conversion rate as interest costs normalize and data rights expenses moderate as a percentage of revenue.
On the revenue side, the betting business remains anchored by contractual minimum revenue guarantees, which management says cover roughly 70% to 80% of that segment's revenue, providing a stable base. The media segment's momentum will depend on continued advertiser adoption of the Moment Engine, where growth could prove uneven as spending patterns evolve.
The prediction markets category — including partnerships with Kalshi and Polymarket and the launch of Prediction.com — represents a significant growth opportunity, though its regulatory landscape remains fluid. Management has reiterated its long-term 2028 targets of 35% adjusted EBITDA margin and at least 60% unlevered free cash flow conversion, providing a framework for evaluating execution in the quarters ahead. From what I see, this is important because it gives a clear benchmark for progress.
My Experience with Tickeron’s AI Tools
I often turn to Tickeron’s tools when reviewing earnings like these. The AI Screener helps me quickly filter stocks by fundamentals and technical signals to put results in broader context. It has become a regular part of my process for identifying comparable names and spotting patterns across the sector.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
GENI's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for GENI turned positive on October 06, 2026. Looking at past instances where GENI's MACD turned positive, the stock continued to rise in 38 of 40 cases over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 03, 2026. You may want to consider a long position or call options on GENI as a result. In 75 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.
GENI moved above its 50-day moving average on November 03, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +7.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where GENI advanced for three days, in 205 of 250 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 177 of 186 cases where GENI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GENI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
GENI broke above its upper Bollinger Band on November 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 19 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.743) is normal, around the industry mean (1.069). P/E Ratio (-10.463) is within average values for comparable stocks, (-42.791). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (17.274). Dividend Yield (0.000) settles around the average of (0.985) among similar stocks. P/S Ratio (2.232) is also within normal values, averaging (71.888).
The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. GENI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 50 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GENI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry InternetSoftwareServices
Advertisement